Is ketogenic diet treatment hepatotoxic for children with intractable epilepsy?

Seizure

Volumn 43, Issue , 2016, Pages 32-38

  Arslan, Nur ^a   Guzel, Orkide ^b   Kose, Engin ^a   Yılmaz, Unsal ^b   Kuyum, Pınar ^a   Aksoy, Betül ^a   Çalık, Tansel ^b  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Behcet Uz Children's Hospital   (Turkey)

Author keywords

Aminotransferase; Children; Epilepsy; Fatty liver; Gallstone; Ketogenic diet

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; GLUCOSE TRANSPORTER 1; PROTEIN; TRIACYLGLYCEROL; AMINOTRANSFERASE;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ADULT; ARTICLE; BRAIN HYPOXIA; BRAIN MALFORMATION; CHILD; CHOLELITHIASIS; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; FEMALE; GENERALIZED EPILEPSY; GLUCOSE TRANSPORTER 1 DEFICIENCY; HUMAN; INFANTILE SPASM; INTRACTABLE EPILEPSY; KETOGENIC DIET; LANDAU KLEFFNER SYNDROME; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MYOCLONIC ASTATIC EPILEPSY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; TUBEROUS SCLEROSIS; ABDOMEN; ANTHROPOMETRY; BLOOD; COMPLICATION; DIAGNOSTIC IMAGING; DIET THERAPY; DRUG RESISTANT EPILEPSY; ECHOGRAPHY; LIVER DISEASES; LONGITUDINAL STUDY; PRESCHOOL CHILD; PROCEDURES; TIME FACTOR;

ABDOMEN; ADOLESCENT; ANTHROPOMETRY; BILIRUBIN; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; DRUG RESISTANT EPILEPSY; FEMALE; HUMANS; KETOGENIC DIET; LIVER DISEASES; LONGITUDINAL STUDIES; MALE; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSAMINASES; TRIGLYCERIDES; ULTRASONOGRAPHY;

EID: 84995814256     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2016.10.024     Document Type: Article

References (49)

1. [1] Wibisono, C., Rowe, N., Beavis, E., Kepreotes, H., Mackie, F.E., Lawson, J.A., et al. Ten-year single-center experience of the ketogenic diet: factors influencing efficacy, tolerability, and compliance. J Pediatr 166 (2015), 1030–1036.
2. [2] Ye, F., Li, X.J., Jiang, W.L., Sun, H.B., Liu, J., Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. J Clin Neurol 11 (2015), 26–31.
3. [3] Lutas, A., Yellen, G., The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci 36 (2013), 32–40.
4. 13C-NMR spectroscopy. J Cereb Blood Flow Metab 35 (2015), 1154–1162.
5. [5] Kim do, Y., Simeone, K.A., Simeone, T.A., Pandya, J.D., Wilke, J.C., Ahn, Y., et al. Ketone bodies mediate antiseizure effects through mitochondrial permeability transition. Ann Neurol 78 (2015), 77–87.
6. [6] Neal, E.G., Chaffe, H., Schwartz, R.H., Lawson, M.S., Edwards, N., Fitzsimmons, G., et al. The ketogenic diet for the treatment of childhood epilepsy: a randomized controlled trial. Lancet Neurol 7 (2008), 500–506.
7. [7] Dressler, A., Trimmel-Schwahofer, P., Reithofer, E., Mühlebner, A., Gröppel, G., Reiter-Fink, E., et al. Efficacy and tolerability of the ketogenic diet in Dravet syndrome—comparison with various standard antiepileptic drug regimen. Epilepsy Res 109 (2015), 81–89.
8. [8] Hallböök, T., Sjölander, A., Åmark, P., Miranda, M., Bjurulf, B., Dahlin, M., Effectiveness of the ketogenic diet used to treat resistant childhood epilepsy in Scandinavia. Eur J Paediatr Neurol 19 (2015), 29–36.
9. [9] Nizamuddin, J., Turner, Z., Rubenstein, J.E., Pyzik, P.L., Kossoff, E.H., Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol 23 (2008), 758–761.
10. [10] Coppola, G., Natale, F., Torino, A., Capasso, R., D'Aniello, A., Pironti, E., et al. The impact of the ketogenic diet on arterial morphology and endothelial function in children and young adults with epilepsy: a case-control study. Seizure 23 (2014), 260–265.
11. [11] Bergqvist, A.G., Schall, J.I., Gallagher, P.R., Cnaan, A., Stallings, V.A., Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Epilepsia 46 (2005), 1810–1819.
12. [12] Caraballo, R.H., Flesler, S., Armeno, M., Fortini, S., Agustinho, A., Mestre, G., et al. Ketogenic diet in pediatric patients with refractory focal status epilepticus. Epilepsy Res 108 (2014), 1912–1916.
13. [13] Kang, H.C., Chung, D.E., Kim, D.W., Kim, H.D., Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 45 (2004), 1116–1123.
14. [14] Nei, M., Ngo, L., Sirven, J.I., Sperling, M.R., Ketogenic diet in adolescents and adults with epilepsy. Seizure 23 (2014), 439–442.
15. [15] Moriyama, K., Watanabe, M., Yamada, Y., Shiihara, T., Protein-losing enteropathy as a rare complication of the ketogenic diet. Pediatr Neurol 52 (2015), 526–528.
16. [16] Ballaban-Gil, K., Callahan, C., O'Dell, C., Pappo, M., Moshé, S., Shinnar, S., Complications of the ketogenic diet. Epilepsia 39 (1998), 744–748.
17. [17] Vieira de Melo, I.S., Da Rocha Ataide, T., Lima de Oliveira, S., Bezerra Bueno, N., Duarte de Freitas, J., Goulart Sant'Ana, A.E., Hepatic fatty acid profile of rats fed a triheptanoin-based ketogenic diet. Nutr Hosp 32 (2015), 265–269.
18. [18] Garbow, J.R., Doherty, J.M., Schugar, R.C., Travers, S., Weber, M.L., Wentz, A.E., et al. Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet. Am J Physiol Gastrointest Liver Physiol 300 (2011), 956–967.
19. [19] Schugar, R.C., Huang, X., Moll, A.R., Brunt, E.M., Crawford, P.A., Role of choline deficiency in the fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet. PLoS One, 8, 2013, e74806, 10.1371/journal.pone.0074806.
20. [20] Jornayvaz, F.R., Jurczak, M.J., Lee, H.Y., Birkenfeld, A.L., Frederick, D.W., Zhang, D., et al. A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain. Am J Physiol Endocrinol Metab 299 (2010), E808–E815, 10.1152/ajpendo.00361.2010.
21. [21] Pissios, P., Hong, S., Kennedy, A.R., Prasad, D., Liu, F.F., Maratos-Flier, E., Methionine and choline regulate the metabolic phenotype of a ketogenic diet. Mol Metab 2 (2013), 306–313.
22. [22] Kennedy, A.R., Pissios, P., Otu, H., Roberson, R., Xue, B., Asakura, K., et al. A high-fat, ketogenic diet induces a unique metabolic state in mice. Am J Physiol Endocrinol Metab 292 (2007), E1724–E1739, 10.1152/ajpendo.00717.2006.
23. [23] da Silveira, V.G., de Paula Cognato, G., Müller, A.P., Figueiró, F., Bonan, C.D., Perry, M.L., et al. Effect of ketogenic diet on nucleotide hydrolysis and hepatic enzymes in blood serum of rats in a lithium-pilocarpine-induced status epilepticus. Metab Brain Dis 25 (2010), 211–217.
24. [24] Hassan, A.M., Keene, D.L., Whiting, S.E., Jacob, P.J., Champagne, J.R., Humphreys, P., Ketogenic diet in the treatment of refractory epilepsy in childhood. Pediatr Neurol 21 (1999), 548–552.
25. [25] Desai, A.A., Thompson, L.M., Abdelmoity, A.T., Kayyali, H., St. Peter, S.D., Management of symptomatic cholelithiasis while on ketogenic diet: a case report. Pediatr Neurol 51 (2014), 439–440.
26. [26] Guzel, O., Yılmaz, U., Uysal, U., Arslan, N., The effect of olive oil-based ketogenic diet on serum lipid levels in epileptic children. Neurol Sci 37 (2016), 465–470.
27. [27] Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972), 499–502.
28. [28] Lo, S.F., Reference intervals for laboratory tests and procedures. Kliegman, R.M., Stanton, B.F., St. Geme, W.J., Schor, N.F., Behrman, R.E., (eds.) Nelson textbook of pediatrics, 19th ed., 2011, Elsevier Inc., Philadelphia p. 2466.
29. [29] Raju, K.N., Gulati, S., Kabra, M., Agarwala, A., Sharma, S., Pandey, R.M., et al. Efficacy of 4:1 (classic) versus 2.5:1 ketogenic ratio diets in refractory epilepsy in young children: a randomized open labeled study. Epilepsy Res 96 (2011), 96–100.
30. [30] Sharma, S., Gulati, S., Kalra, V., Agarwala, A., Kabra, M., Seizure control and biochemical profile on the ketogenic diet in young children with refractory epilepsy—Indian experience. Seizure 18 (2009), 446–449.
31. [31] Groesbeck, D.K., Bluml, R.M., Kossoff, E.H., Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol 48 (2006), 978–981.
32. [32] Stevens, C.E., Turner, Z., Kossoff, E.H., Hepatic dysfunction as a complication of combined valproate and ketogenic diet. Pediatr Neurol 54 (2016), 82–84.
33. [33] Caballero, F., Fernández, A., Matías, N., Martínez, L., Fucho, R., Elena, M., et al. Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione. J Biol Chem 285 (2010), 18528–18536.
34. [34] Tendler, D., Lin, S., Yancy, W.S. Jr., Mavropoulos, J., Sylvestre, P., Rockey, D.C., et al. The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci 52 (2007), 589–593.
35. [35] Okuda, T., Morita, N., A very low carbohydrate ketogenic diet prevents the progression of hepatic steatosis caused by hyperglycemia in a juvenile obese mouse model. Nutr Diabetes, 2, 2012, e50, 10.1038/nutd.2012.24.
36. [36] Pérez-Guisado, J., Muñoz-Serrano, A., The effect of the Spanish Ketogenic Mediterranean Diet on non-alcoholic fatty liver disease: a pilot study. J Med Food 14 (2011), 677–680.
37. [37] Noguchi, Y., Nishikata, N., Shikata, N., Kimura, Y., Aleman, J.O., Young, J.D., et al. Ketogenic essential aminoacids modulate lipid synthetic pathways and prevent hepatic steatosis in mice. PLoS One, 5(8), 2010, e12057, 10.1371/journal.pone.0012057.
38. [38] Pickens, M.K., Yan, J.S., Ng, R.K., Ogata, H., Grenert, J.P., Beysen, C., et al. Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis. J Lipid Res 50 (2009), 2072–2082.
39. [39] Miller, C.A., Corbin, K.D., da Costa, K.A., Zhang, S., Zhao, X., Galanko, J.A., et al. Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study. Am J Clin Nutr 100 (2014), 778–786.
40. [40] Gan, L., Xiang, W., Xie, B., Yu, L., Molecular mechanisms of fatty liver in obesity. Front Med 9 (2015), 275–287.
41. [41] Shimomura, I., Matsuda, M., Hammer, R.E., Bashmakov, Y., Brown, M.S., Goldstein, J.L., Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6 (2000), 77–86.
42. [42] Lee, A.H., Scapa, E.F., Cohen, D.E., Glimcher, L.H., Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320 (2008), 1492–1496.
43. [43] Lee, J.N., Ye, J., Proteolytic activation of sterol regulatory element binding protein induced by cellular stress through depletion of Insig-1. J Biol Chem 279 (2004), 45257–45265.
44. [44] Horton, J.D., Goldstein, J.L., Brown, M.S., SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109 (2002), 1125–1131.
45. [45] Zhang, Y.L., Hernandez-Ono, A., Siri, P., Weisberg, S., Conlon, D., Graham, M.J., et al. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J Biol Chem 281 (2006), 37603–37615.
46. [46] Gökçe, S., Yıldırım, M., Erdoğan, D., A retrospective review of children with gallstone: single-center experience from Central Anatolia. Turk J Gastroenterol 25 (2014), 46–53.
47. [47] Fradin, K., Racine, A.D., Belamarich, P.F., Obesity and symptomatic cholelithiasis in childhood: epidemiologic and case-control evidence for a strong relation. J Pediatr Gastroenterol Nutr 58 (2014), 102–106.
48. [48] Mehta, S., Lopez, M.E., Chumpitazi, B.P., Mazziotti, M.V., Brandt, M.L., Fishman, D.S., Clinical characteristics and risk factors for symptomatic pediatric gallbladder disease. Pediatrics 129 (2012), e82–e88, 10.1542/peds.2011-0579.
49. [49] Walker, S.K., Maki, A.C., Cannon, R.M., Foley, D.S., Wilson, K.M., Galganski, L.A., et al. Etiology and incidence of pediatric gallbladder disease. Surgery 154 (2013), 927–931.